“horizon-therapeutics” Archives

Entry Author Date Location
AbbVie Commits $750M to Genmab Bispecific Antibody Cancer Drug Deal 06/10/20 National
Annovis Bio Gets $12M in IPO to Target Trio of Neurotoxic Proteins 01/29/20 New York
Bio Roundup: Coronavirus Concerns, Sarepta’s CRL, Eye Drug OK’d & More 01/24/20 National
Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment 01/22/20 National
Horizon Therapeutics Receives $7,294,000 New Financing 03/31/10 Detroit Ann Arbor
Page 1 of 1